Skip to main content
. Author manuscript; available in PMC: 2016 Dec 19.
Published in final edited form as: Cancer Discov. 2015 May 1;5(7):768–781. doi: 10.1158/2159-8290.CD-14-1040

Figure 4. Small molecule inhibitors of eIF4A reduce MYC protein levels and suppress cancer cell proliferation.

Figure 4

A. SW480 cells were treated with BEZ235 (200nM) and the indicated concentrations of silvestrol for 48h and analyzed by immunoblotting (n=3).

B. SW480 cells were incubated with BEZ235 (200nM), Silvestrol (25nM) or both. RNA was isolated after 48h and subjected to RQ-PCR analysis (n=2).

C. Immunoblots of four colorectal cell lines upon treatment with increasing concentration of silvestrol or solvent control (n=2).

D. Ls174T cells incubated with increasing concentration of silvestrol for 48h were subjected to RQ-PCR and analyzed for markers of cell cycle arrest (CDKN1A) and differentiation (MUC2) (n=2).

E. Colony formation assay stained with crystal violet. The indicated cell lines were incubated with silvestrol (25nM) for 5 days.